Utility of additional endobronchial biopsy for the diagnosis of sarcoidosis
##plugins.themes.themeTen.article.main##
Keywords
sarcoidosis, endobronchial biopsy, diagnostic yield
Abstract
Background and Aim: The identification of nonnecrotizing granulomas is essential for the diagnosisof sarcoidosis. For this purpose, the effectiveness of transbronchial lung biopsy (TBLB) and transbronchial needle aspiration (TBNA) is established; however, the role of endobronchial biopsy (EBB) remains uncertain. This study aimed to assess the additional diagnostic value of EBB and factors affecting its diagnostic yield for the diagnosis of sarcoidosis.
Methods: This retrospective cross-sectional study included 46 patients who were preliminarily diagnosed with sarcoidosis and admitted to the Department of Respiratory Medicine of Shizuoka Saiseikai General Hospital between August 2016 and April 2023. Among them, 25 patients who underwent EBB were divided into EBB (diagnosed by EBB) and nonEBB (diagnosed by TBLB, TBNA, or clinically) groups. The patient background characteristics were analyzed to identify factors affecting the diagnostic yield of EBB.
Results: The diagnostic yield of EBB alone was 24% (6 of 25 patients). There were no significant differences in the patients’ background characteristics between the two groups. When EBB was added, the diagnostic yield of TBLB increased from 47.8% to 60.9% and that of TBNA increased from 52.6% to 57.9%. In three patients, EBB alone provided histological diagnosis.
Conclusions: Although EBB alone had a relatively low diagnostic yield, it led to a diagnosis in some cases. Combining TBLB or TBNA with EBB may enhance overall diagnostic yield.
References
2. Bjemer L, Thunell M, Rosenhall L, et al. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85:229-234.
3. Bilaceroglu S, Perim K, Gunel O, et al. Combining transbronchial aspiration with
endobronchial and transbronchial biopsy in sarcoidosis. Monaldi Arch Chest Dis 1999; 54:217- 223.
4. Shorr AF, Torrington KG, Hnatiuk OW, et al. Endobronchial biopsy for sarcoidosis: a
prospective study. Chest 2001; 120:109-14.
5. Benzaquen S, Aragaki-Nakahodo AA. Bronchoscopic modalities to diagnose sarcoidosis. Curr Opin Pulm Med 2017; 23:433-438.
6. Rocco Trisolini, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations. Respirology (2015) 20, 226- 234.
7. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160:736–755.
8. The Japanese Society of Sarcoidosis and Other Granulomatous Disorders (JSSOG). Diagnostic standard and guideline for sarcoidosis-2006. Jpn J Sarcoidosis and Granulomatous Disorders. 2007; 27: 89–102.
9. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013; 48: 452–458.
10. Dziedzic, DA, Peryt A, Orlowski T. The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis. Clin. Respir. J 2017; 11: 58–63
11. Torrington KG, Shorr AF, Parker JW. Endobronchial disease and racial differences in pulmonary sarcoidosis. Chest 1997;111:619-22.
12. Ishii H, Otani S, Iwata A, et al. Limited role of auxiliary endobronchial biopsy in the diagnosis of Japanese patients with sarcoidosis. Tohoku J Exp Med 2011; 223:119-23.
13. Scadding JG, Mitchell DN. Sarcoidosis. Chapman and Hall, London, 1985.
14. Inoue Y, Inui N, Suda T, et al. Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis. PLoS One. 2015 Nov 17;10(11): e0143371.
##plugins.themes.themeTen.article.sidebar##
##plugins.themes.themeTen.article.details##
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
